MyPal is a Horizon 2020 (H2020) Research & Innovation Action (RIA) aiming to foster palliative care for people with cancer by leveraging patient reported outcome (PRO) systems through their adaptation to the personal needs of the person with cancer and his/her caregiver(s).
MyPal aspires to empower people with cancer and their caregivers in capturing more accurately their symptoms/conditions, communicate them in a seamless and effective way to their healthcare providers and, ultimately, foster the time for action through the prompt identification of important deviations in the patient’s state and Quality of Life (QoL).
MyPal exploits advances in digital health to support patients, family members and healthcare providers in gaining value through a systematic and comprehensive PRO-based intervention.
Company Details
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://mypal-project.eu/
- Keywords
- SWISDATA gGmbH.
Mypal H2020 Questions
Mypal H2020's website is https://mypal-project.eu/
Mypal H2020's LinkedIn profile is https://www.linkedin.com/company/mypal-h2020
Mypal H2020's industry is
Hospitals and Health Care
Mypal H2020's top competitors are
American Society Of Hematology,
Purewater Environmental Services Ltd,
Health Experiences Research Canada,
Hubpy,
Phytowelt Greentechnologies Gmbh,
C.i.p Citizens In Power,
Swisdata Ggmbh,
Fluitec.
Mypal H2020's categories are Hospitals and Health Care
